BridgeMD
New treatment option for Cerebral Hemorrhage
Official title Active Removal of IntraCerebral Hematoma Via Active Irrigation
ClinicalTrials.gov ID: NCT05118997
What this study is testing
- What it's testing
- Study evaluating if active irrigation by IRRAflow® with infusion of tPA will reduce the time needed for clearance of intracerebral and intraventricular hemorrhage compared with passive drainage.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age \>18 years of age
- Need of EVD
- Active treatment
- Signed informed consent obtained a. Based on institutional and country laws
- Spontaneous ICH with maximum 30 square cm's
You likely can't join if
- Age \< 18 years
- No need of EVD
- Patient has fixed and dilated pupils
- Coagulopathy uncorrectable
- Vascular pathology (e.g. Aneurysm involvement, AVM involvement)
- Pregnant women
See the full eligibility criteria
- Age \>18 years of age
- Need of EVD
- Active treatment
- Signed informed consent obtained a. Based on institutional and country laws
- Spontaneous ICH with maximum 30 square cm's
- If needed, normal coagulation profile (PT, PTT, platelet count)
- Treatment within 72 hours of ictus
- Ability to administer 2.0 mg of tPA per day for 3 days
- Age \< 18 years
- No need of EVD
- Patient has fixed and dilated pupils
- Coagulopathy uncorrectable
- Vascular pathology (e.g. Aneurysm involvement, AVM involvement)
- Pregnant women
The study team makes the final eligibility decision.
Where it's taking place
- Helsinki, Finland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Helsinki, Finland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.